Zhi-Hao Zhang Selected Research

Zhi-Hao Zhang Research Topics

Disease

9	Fibrosis (Cirrhosis) 01/2024 - 01/2016
3	Spinal Cord Injuries (Spinal Cord Injury) 02/2024 - 08/2023
2	Inflammation (Inflammations) 02/2024 - 01/2017
2	Ureteral Obstruction 01/2024 - 10/2022
2	Chronic Renal Insufficiency 02/2023 - 12/2016
2	Segmental glomerulosclerosis 10/2020 - 01/2016
2	Chronic Tubulointerstitial Nephropathy 01/2018 - 02/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2024
1	Hematuria 08/2023
1	Purpura 08/2023
1	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2023
1	Nephritis 08/2023
1	Infections 08/2023
1	Abdominal Pain (Pain, Abdominal) 02/2022
1	Renal Insufficiency (Renal Failure) 02/2022
1	Pica (Geophagia) 01/2022
1	Air Embolism (Gas Embolism) 06/2021
1	Disease Progression 11/2020
1	Edema (Dropsy) 01/2020
1	Pathologic Processes 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	COVID-19 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Neoplasms (Cancer) 06/2019
1	Hepatocellular Carcinoma (Hepatoma) 06/2019
1	Uremia 12/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2017
1	Thrombocytopenia (Thrombopenia) 10/2017
1	Thrombosis (Thrombus) 10/2017
1	Hemorrhage 10/2017
1	Fatigue 06/2017
1	Kidney Diseases (Kidney Disease) 12/2016
1	Anemia 12/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2004
5	Adenine FDA LinkGeneric 10/2022 - 02/2016
3	CreatinineIBA 08/2023 - 12/2016
2	Urea (Carbamide)FDA LinkGeneric 08/2023 - 12/2016
2	TriterpenesIBA 03/2020 - 02/2018
2	CateninsIBA 03/2020 - 02/2018
2	ethyl acetateIBA 02/2018 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 02/2016
1	Versicans (Versican)IBA 02/2024
1	Peptides (Polypeptides)IBA 02/2024
1	phytobacteriomycin (PBM)IBA 02/2024
1	schizandrin AIBA 01/2024
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 08/2023
1	Serum AlbuminIBA 08/2023
1	NitrogenIBA 08/2023
1	Complement C3 (C3 Complement)IBA 08/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 02/2023
1	Phospholipases A2 (Phospholipase A2)IBA 02/2023
1	artemisinin (artemisinine)IBA 10/2022
1	artenimol (dihydroartemisinin)IBA 10/2022
1	Azacitidine (5 Azacytidine)FDA Link 10/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	MethyltransferasesIBA 10/2022
1	IonsIBA 02/2022
1	MercuryIBA 02/2022
1	KaolinIBA 01/2022
1	Oxygen (Dioxygen)IBA 06/2021
1	LigandsIBA 03/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2020
1	asiatic acidIBA 03/2020
1	15-deoxyprostaglandin J2IBA 03/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Liraglutide FDA Link 01/2020
1	CholesterolIBA 01/2020
1	LipidsIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 06/2019
1	AcidsIBA 02/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	ElectrolytesIBA 12/2017
1	Factor Xa InhibitorsIBA 10/2017
1	Fondaparinux (Arixtra)FDA Link 10/2017
1	AnticoagulantsIBA 10/2017
1	Epoxy Resins FDA Link 06/2017
1	AlloysIBA 06/2017
1	Monoamine Oxidase (MAO)IBA 06/2017
1	SolutionsIBA 06/2017
1	Beclin-1IBA 01/2017
1	NF-kappa B (NF-kB)IBA 12/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	aristolochic acid I (aristolochic acid)IBA 12/2016
1	AntioxidantsIBA 11/2016
1	1-Butanol (n Butanol)IBA 02/2016

Therapy/Procedure

4	Therapeutics 11/2020 - 10/2017
3	Low-Level Light Therapy (LLLT) 02/2024 - 08/2023
1	Spinal Injections 02/2024
1	Oral Administration 10/2022
1	Hyperbaric Oxygenation 06/2021
1	Liver Transplantation 06/2019
1	Renal Dialysis (Hemodialysis) 12/2017
1	Contraindications 10/2017
1	Ligation 11/2016